Arkolith/Insider Trading/AVNS/Form 4/A

Galovan Scott Michael

SVP, Chief Financial OfficerAVANOS MEDICAL, INC. (AVNS) · full profile →Form 4/A · filed Apr 1, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 13, 2026Grant(A)29K—$0140K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 13, 2026Grant(A)70K—$096K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001606498-26-000040) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML